Gesynta Pharma (private company)

See something wrong or missing? Let us know
Offices:
Stockholm
Registration number:
559103-6628
Business model:
B2B
Investors:
we tracked 4 investors
You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Total investments received (USD) - we tracked 3 transactions

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Gesynta Pharma AB leverages expertise in arachidonic acid research to explore niche indications in chronic inflammation for mPGES-1 inhibitors.

Companies with similar profile to Gesynta Pharma:

CompanyCriteria
Sweden Athera
56%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • At least one other investor: Karolinska Development
Sweden Trialbee
56%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Novo A/S
  • Total raised in a similar range: 10M+ USD
Finland Forendo Pharma
54%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: Karolinska Development
  • Total raised in a similar range: 10M+ USD
Sweden AttgeNO
46%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
Norway Smartfish
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Norway Oncoinvent
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Hadean Ventures
  • Total raised in a similar range: 10M+ USD
Sweden Airsonett
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden InDex Pharmaceuticals
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden AMRA
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden OxThera
45%
  • Similar verticals: Pharma
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Sweden BoneSupport
45%
  • Similar verticals: Health services
  • Similar business models: B2B
  • At least one vc investor: Industrifonden
  • Total raised in a similar range: 10M+ USD
Finland Nanoform Finland
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Spain Bigfinite
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Norway Vaccibody
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Asarina Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Spain Ona Therapeutics
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
44%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Total raised in a similar range: 10M+ USD